Ad is loading...
MMMPX
Price
$21.68
Change
-$0.14 (-0.64%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

MMMPX vs RNWFX

Header iconMMMPX vs RNWFX Comparison
Open Charts MMMPX vs RNWFXBanner chart's image
Morgan Stanley Inst Emerging Mkts R6
Price$21.68
Change-$0.14 (-0.64%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
MMMPX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MMMPX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MMMPX is a StrongSell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. MMMPX (532M). MMMPX pays higher dividends than RNWFX: MMMPX (2.43) vs RNWFX (1.51). MMMPX was incepted earlier than RNWFX: MMMPX (11 years) vs RNWFX (23 years). MMMPX is a more actively managed with annual turnover of: 34.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than MMMPX: RNWFX (250) vs MMMPX (5000000). MMMPX annual gain was more profitable for investors over the last year : 14.49 vs. RNWFX (11.54). RNWFX return over 5 years is better than : 17.17 vs. MMMPX (-9.31).
MMMPXRNWFXMMMPX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years23 years-
Gain YTD8.7817.099124%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets532M60.9B1%
Annual Yield % from dividends2.431.51161%
Returns for 1 year14.4911.54126%
Returns for 3 years-20.34-14.55140%
Returns for 5 years-9.3117.17-54%
Returns for 10 years-4.8141.00-12%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics